A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

PHASE4RecruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

August 28, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Hodgkin Lymphoma
Interventions
DRUG

Brentuximab Vedotin

Brentuximab Vedotin IV infusion

DRUG

Doxorubicin

Doxorubicin IV infusion

DRUG

Vinblastine

Vinblastine IV infusion

DRUG

Dacarbazine

Dacarbazine IV infusion

Trial Locations (11)

110029

RECRUITING

AIIMS, New Delhi

110085

RECRUITING

Rajiv Gandhi Cancer Hospital, Delhi

395002

RECRUITING

Unique Hospital Multispeciality and Research Institute, Surat

410210

NOT_YET_RECRUITING

ACTREC, Navi Mumbai

411004

RECRUITING

DMH, Pune

422002

NOT_YET_RECRUITING

HCG Manavata Cancer Centre, Nashik

520002

RECRUITING

HCG City Cancer Centre, Vijayawada

560027

NOT_YET_RECRUITING

HCG Cancer Centre, Bangalore

605006

RECRUITING

JIPMER, Puducherry

700014

RECRUITING

NRS Medical college & Hospital, Kolkata, Kolkata

781032

RECRUITING

Gauhati Medical college and Hospital, Guwahati

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY